首頁 > 市場調查報告書 > 材料/化學品

包裝/容器

市場調查報告書

商品編碼

1815420

2025年全球軟膠囊市場報告

Softgel Capsules Global Market Report 2025

出版日期: 2025年09月09日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年軟膠囊市場規模將強勁成長，到2029年將達到123.9億美元，複合年成長率為8.8%。預測期內的成長可歸因於醫療保健行業的擴張、個性化客製化醫療、機能性食品和飲料市場、天然和有機趨勢、對老齡化人口的關注以及綠色和永續舉措。預測期內的主要趨勢包括膳食補充劑的創新、永續性措施、對天然和偏好的偏好以及法規遵循。

未來五年8.8%的成長率預測，較我們先前對該市場的預測略有下降0.3%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易限制可能會影響美國營養保健品公司，因為這會增加從美國和韓國進口的明膠封裝系統和脂質製劑技術的成本，從而可能推遲產品上市並增加營養保健品的生產成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響可能更為廣泛。

慢性疾病（尤其是心血管疾病）的日益普及預計將推動軟膠囊市場的成長。心臟病、中風、糖尿病和關節炎等病程超過一年的慢性疾病需要持續的營養和醫療保健。軟膠囊是慢性病患者首選的營養補充劑輸送系統，這推動了此類膠囊的需求成長。根據印度醫學研究理事會及印度登記總署及人口普查專員的一項研究，截至2022年9月，印度約佔全球心臟病負擔的60%。這凸顯了軟膠囊在滿足慢性病（尤其是心血管疾病）患者營養需求方面所能發揮的重要作用。

全球軟膠囊：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球軟膠囊市場：成長率分析
全球軟膠囊市場表現：規模與成長，2019-2024
全球軟膠囊市場預測：2024-2029年及2034年規模與成長
全球軟膠囊：總目標市場（TAM）

第6章市場細分

全球軟膠囊市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
明膠或動物衍生
非動物衍生
全球軟膠囊市場製造商、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
製藥公司
營養補充品公司
化妝品公司
契約製造組織
軟膠囊
全球軟膠囊市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
制酸劑和腸道調節劑
抗貧血藥
抗發炎藥物
抗生素和抗菌藥物
咳嗽和感冒藥
保健品
維生素和營養補充劑
懷孕
全球軟膠囊市場：按明膠或動物基（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
豬肉明膠
牛明膠
魚明膠
全球軟膠囊市場：按非動物來源、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
素食膠囊
明膠替代品

第7章區域和國家分析

全球軟膠囊市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球軟膠囊市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

軟膠囊市場：競爭格局
軟膠囊市場：公司簡介
- Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
- Eurocaps Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Aenova Group GmbH Overview, Products and Services, Strategy and Financial Analysis
- Sirio Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Procaps Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

Captek Softgel International Inc.
Fuji Capsule Co. Ltd.
Hunan ER-KANG Pharmaceutical Co. Ltd.
Curtis Health Caps SA
Delpharm Holding SAS
Estrellas Life Sciences Pvt. Ltd.
Elnova Pharma LLP
Soft Gel Technologies Inc.
Weihai Baihe Biology Technological Co. Ltd.
United Laboratories
Robinson Pharma Inc.
Thermo Fisher Scientific Inc.
Best Formulations Inc.
DCC PLC
Biophar Lifesciences Pvt. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年軟膠囊市場：提供新機會的國家
2029年軟膠囊市場：細分市場帶來新機會
2029年軟膠囊市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r22963u

Soft gelatin capsules, often termed softgels or soft elastic capsules, dissolve more rapidly compared to hard gelatin capsules and are employed for containing liquid or powder medications. They serve as a vehicle for delivering pharmaceuticals and a range of nutritional supplements, such as omega-3 fish oils.

Two primary categories of soft gel capsules exist such as gelatin or animal-based and non-animal based. Gelatin or animal-based capsules are derived from connective tissues of cattle and pigs, utilizing processes involving boiling, fractured bones, and deteriorating animal hides for gelatin production. Various manufacturers, including pharmaceutical companies, nutraceutical companies, cosmeceutical companies, contract manufacturing organizations, and softgel capsule manufacturers, utilize these capsules in multiple applications. These applications span antacid and anti-flatulent preparations, anti-anemic preparations, anti-inflammatory drugs, antibiotics, cough and cold preparations, health supplements, vitamin D dietary supplements, and pregnancy-related medications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The soft-gel capsules market research report is one of a series of new reports from The Business Research Company that provides soft-gel capsules market statistics, including soft-gel capsules industry global market size, regional shares, competitors with a soft-gel capsules market share, detailed soft-gel capsules market segments, market trends and opportunities, and any further data you may need to thrive in the soft-gel capsules industry. This soft-gel capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The softgel capsules market size has grown strongly in recent years. It will grow from $8.29 billion in 2024 to $8.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to pharmaceutical and nutraceutical demand, consumer preference for oral dosage forms, customization and formulation flexibility, enhanced bioavailability, product differentiation and branding.

The softgel capsules market size is expected to see strong growth in the next few years. It will grow to $12.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expanding healthcare industry, personalized and customized healthcare, functional food and beverage market, natural and organic trends, focus on elderly population, green and sustainable initiatives. Major trends in the forecast period include nutraceutical innovation, sustainability initiatives, natural and organic preferences, regulatory compliance.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade limitations could impact U.S. nutraceutical companies by increasing costs of gelatin-based encapsulation systems and lipid formulation technologies imported from Brazil and South Korea, potentially delaying product launches and raising dietary supplement production costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases, particularly cardiovascular ailments, is anticipated to be a key driver for the growth of the soft gel capsules market. Chronic illnesses, lasting a year or more, such as heart disease, stroke, diabetes, and arthritis, necessitate ongoing nutritional and medical care. Soft gel capsules serve as a preferred delivery system for nutritional supplements required by patients with chronic conditions, contributing to the rising demand for these capsules. As of September 2022, studies from the Indian Council of Medical Research and the Registrar General and Census Commissioner of India indicate that approximately 60% of the global burden of heart disease is attributed to India. This underscores the significant role soft gel capsules play in addressing the nutritional needs of individuals with chronic diseases, particularly in the context of cardiovascular ailments.

The growth of the softgel capsules market is expected to be driven by the rising global aging population. This term refers to changes in a population's age distribution that lead to a higher proportion of elderly individuals. As people age, their ability to swallow conventional pills or tablets often diminishes due to factors like decreased swallowing ability or dry mouth. Consequently, older adults tend to prefer softgel capsules, which feature a smooth, gelatinous coating that facilitates easier swallowing. For example, a report published by the US-based Pew Research Center Organization in January 2024 indicated that the geriatric population is projected to grow by 0.5% by 2054, with an increase of just 0.2% in 2024. Therefore, the increasing global aging population is propelling the growth of the softgel capsules market.

A noteworthy trend in the soft gel capsules market is the adoption of technological advancements. Key players in the market are actively developing new products with cutting-edge technologies to maintain their competitive edge. For instance, in April 2023, International Flavors & Fragrances (IFF), Inc., a leading US-based company in flavors, fragrances, and cosmetic actives manufacturing, introduced VERDIGEL SC. This innovative pectin-based technology, designed as a carrageenan-free, vegan softgel premix, enhances softgel quality, performance, and process efficiency. VERDIGEL SC is easily integrated into existing operations, requiring only the addition of water and a plasticizer to produce high-performance softgels. This technological advancement underscores the commitment of major industry players to continually innovate and offer superior products in the soft gel capsules market.

Major players in the soft gel capsules market are actively pursuing strategic collaborations with prominent manufacturing companies to reinforce their market position. These strategic collaborations empower companies to establish alliances with partners possessing the expertise needed to translate conceptual ideas into tangible products. In August 2022, Aenova Group GmbH, a Germany-based contract manufacturer and development service provider in the pharmaceutical and healthcare industries, initiated a strategic partnership with Microcaps, a Switzerland-based high-precision microencapsulation technology company. This collaboration is geared towards the faster and improved development and production of pharmaceuticals, food supplements, and various other products. Leveraging Microcaps' expertise in creative, high-precision microencapsulation, Aenova aims to enhance its capabilities and offerings in the market.

In November 2023, Permira, a UK-based private equity firm with a significant global footprint, acquired Ergomed Public Limited Company for an undisclosed sum. This acquisition is intended to enhance Permira's investments in the healthcare sector. Ergomed PLC, which provides specialized services to the pharmaceutical industry, aligns seamlessly with Permira's focus on companies that present growth opportunities in the healthcare and life sciences sectors. Ergomed Public Limited Company is a pharmaceutical firm based in the UK.

Major companies operating in the softgel capsules market are Catalent Inc., Eurocaps Ltd., Aenova Group GmbH, Sirio Pharma Co. Ltd., Procaps Laboratories Inc., Captek Softgel International Inc., Fuji Capsule Co. Ltd., Hunan ER-KANG Pharmaceutical Co. Ltd., Curtis Health Caps SA, Delpharm Holding SAS, Estrellas Life Sciences Pvt. Ltd., Elnova Pharma LLP, Soft Gel Technologies Inc., Weihai Baihe Biology Technological Co. Ltd., United Laboratories, Robinson Pharma Inc., Thermo Fisher Scientific Inc., Best Formulations Inc., DCC PLC, Biophar Lifesciences Pvt. Ltd., Swisschem Healthcare, Krishlar Pharmaceuticals, Amzor Healthcare Pvt. Ltd., Medgel Pvt. Ltd., Amway Corp., Welex Laboratories Pvt. Ltd., NutraScience Labs Inc., Nutrifynn Caps Inc., NutraPak USA, Nutrafill LLC, Nutricap Labs LLC, Nutra Manufacturing Inc., Ion Labs Inc., Vitakem Nutraceutical Inc., Private Label Nutraceuticals LLC, NutraLab Canada Ltd., Makers Nutrition LLC

North America was the largest region in the soft gel capsules market in 2024. The regions covered in the softgel capsules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the softgel capsules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The soft gel capsules market consists of sales of liquid or semisolid-filled capsules, chewable, suckers, twist-offs, and meltable capsules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Softgel Capsules Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on softgel capsules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for softgel capsules ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The softgel capsules market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Gelatin Or Animal Based; Non-Animal Based
2) By Manufacturers: Pharmaceutical Companies; Nutraceutical Companies; Cosmeceutical Companies; Contract Manufacturing Organizations; Softgel Capsules
3) By Application: Antacid And Anti-Flatulent Preparations; Anti-Anemic Preparations; Anti-Inflammatory Drugs; Antibiotic And Antibacterial Drugs; Cough And Cold Preparations; Health Supplement; Vitamin And Dietary Supplement; Pregnancy
Subsegments:
1) By Gelatin Or Animal Based: Porcine Gelatin; Bovine Gelatin; Fish Gelatin
2) By Non-Animal Based: Vegetarian Capsules; Gelatin Alternatives
Companies Mentioned: Catalent Inc.; Eurocaps Ltd.; Aenova Group GmbH; Sirio Pharma Co. Ltd.; Procaps Laboratories Inc.; Captek Softgel International Inc.; Fuji Capsule Co. Ltd.; Hunan ER-KANG Pharmaceutical Co. Ltd.; Curtis Health Caps SA; Delpharm Holding SAS; Estrellas Life Sciences Pvt. Ltd.; Elnova Pharma LLP; Soft Gel Technologies Inc.; Weihai Baihe Biology Technological Co. Ltd.; United Laboratories; Robinson Pharma Inc.; Thermo Fisher Scientific Inc.; Best Formulations Inc.; DCC PLC; Biophar Lifesciences Pvt. Ltd.; Swisschem Healthcare; Krishlar Pharmaceuticals; Amzor Healthcare Pvt. Ltd.; Medgel Pvt. Ltd.; Amway Corp.; Welex Laboratories Pvt. Ltd.; NutraScience Labs Inc.; Nutrifynn Caps Inc.; NutraPak USA; Nutrafill LLC; Nutricap Labs LLC; Nutra Manufacturing Inc.; Ion Labs Inc.; Vitakem Nutraceutical Inc.; Private Label Nutraceuticals LLC; NutraLab Canada Ltd.; Makers Nutrition LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Softgel Capsules Market Characteristics

3. Softgel Capsules Market Trends And Strategies

4. Softgel Capsules Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Softgel Capsules Growth Analysis And Strategic Analysis Framework

5.1. Global Softgel Capsules PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Softgel Capsules Market Growth Rate Analysis
5.4. Global Softgel Capsules Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Softgel Capsules Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Softgel Capsules Total Addressable Market (TAM)

6. Softgel Capsules Market Segmentation

6.1. Global Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin Or Animal Based
Non-Animal Based
6.2. Global Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Nutraceutical Companies
Cosmeceutical Companies
Contract Manufacturing Organizations
Softgel Capsules
6.3. Global Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antacid And Anti-Flatulent Preparations
Anti-Anemic Preparations
Anti-Inflammatory Drugs
Antibiotic And Antibacterial Drugs
Cough And Cold Preparations
Health Supplement
Vitamin And Dietary Supplement
Pregnancy
6.4. Global Softgel Capsules Market, Sub-Segmentation Of Gelatin Or Animal Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Porcine Gelatin
Bovine Gelatin
Fish Gelatin
6.5. Global Softgel Capsules Market, Sub-Segmentation Of Non-Animal Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vegetarian Capsules
Gelatin Alternatives

7. Softgel Capsules Market Regional And Country Analysis

7.1. Global Softgel Capsules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Softgel Capsules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Softgel Capsules Market

8.1. Asia-Pacific Softgel Capsules Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Softgel Capsules Market

9.1. China Softgel Capsules Market Overview
9.2. China Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Softgel Capsules Market

10.1. India Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Softgel Capsules Market

11.1. Japan Softgel Capsules Market Overview
11.2. Japan Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Softgel Capsules Market

12.1. Australia Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Softgel Capsules Market

13.1. Indonesia Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Softgel Capsules Market

14.1. South Korea Softgel Capsules Market Overview
14.2. South Korea Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Softgel Capsules Market

15.1. Western Europe Softgel Capsules Market Overview
15.2. Western Europe Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Softgel Capsules Market

16.1. UK Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Softgel Capsules Market

17.1. Germany Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Softgel Capsules Market

18.1. France Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Softgel Capsules Market

19.1. Italy Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Softgel Capsules Market

20.1. Spain Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Softgel Capsules Market

21.1. Eastern Europe Softgel Capsules Market Overview
21.2. Eastern Europe Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Softgel Capsules Market

22.1. Russia Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Softgel Capsules Market

23.1. North America Softgel Capsules Market Overview
23.2. North America Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Softgel Capsules Market

24.1. USA Softgel Capsules Market Overview
24.2. USA Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Softgel Capsules Market

25.1. Canada Softgel Capsules Market Overview
25.2. Canada Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Softgel Capsules Market

26.1. South America Softgel Capsules Market Overview
26.2. South America Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Softgel Capsules Market

27.1. Brazil Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Softgel Capsules Market

28.1. Middle East Softgel Capsules Market Overview
28.2. Middle East Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Softgel Capsules Market

29.1. Africa Softgel Capsules Market Overview
29.2. Africa Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Softgel Capsules Market, Segmentation By Manufacturers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Softgel Capsules Market Competitive Landscape And Company Profiles

30.1. Softgel Capsules Market Competitive Landscape
30.2. Softgel Capsules Market Company Profiles
- 30.2.1. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eurocaps Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Aenova Group GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sirio Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Procaps Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Softgel Capsules Market Other Major And Innovative Companies

31.1. Captek Softgel International Inc.
31.2. Fuji Capsule Co. Ltd.
31.3. Hunan ER-KANG Pharmaceutical Co. Ltd.
31.4. Curtis Health Caps SA
31.5. Delpharm Holding SAS
31.6. Estrellas Life Sciences Pvt. Ltd.
31.7. Elnova Pharma LLP
31.8. Soft Gel Technologies Inc.
31.9. Weihai Baihe Biology Technological Co. Ltd.
31.10. United Laboratories
31.11. Robinson Pharma Inc.
31.12. Thermo Fisher Scientific Inc.
31.13. Best Formulations Inc.
31.14. DCC PLC
31.15. Biophar Lifesciences Pvt. Ltd.

32. Global Softgel Capsules Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Softgel Capsules Market

34. Recent Developments In The Softgel Capsules Market

35. Softgel Capsules Market High Potential Countries, Segments and Strategies

35.1 Softgel Capsules Market In 2029 - Countries Offering Most New Opportunities
35.2 Softgel Capsules Market In 2029 - Segments Offering Most New Opportunities
35.3 Softgel Capsules Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies